These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 6056370)
1. Quality assurance of raw materials. Jenkins JW Med Serv J Can; 1967 Mar; 23(3):252-61. PubMed ID: 6056370 [No Abstract] [Full Text] [Related]
2. WHO Expert Committee on Specifications for Pharmaceutical Preparations. World Health Organ Tech Rep Ser; 2003; 917():i-viii, 1-125, back cover. PubMed ID: 15024913 [TBL] [Abstract][Full Text] [Related]
3. Quality assurance during the production process. Tucker JD Med Serv J Can; 1967 Mar; 23(3):262-9. PubMed ID: 6056371 [No Abstract] [Full Text] [Related]
5. [Quality assurance is based on local conditions]. Knudsen R Ugeskr Laeger; 1991 Apr; 153(14):1004-5. PubMed ID: 2024311 [No Abstract] [Full Text] [Related]
6. Roadmap for implementation of quality by design (QbD) for biotechnology products. Rathore AS Trends Biotechnol; 2009 Sep; 27(9):546-53. PubMed ID: 19647883 [TBL] [Abstract][Full Text] [Related]
7. [Role of an association in promoting pharmaceutical quality assurance: transfer of know-how based on the buddy system]. Ba A; Courcambeck A; Degui H Med Trop (Mars); 2006 Dec; 66(6):538-41. PubMed ID: 17286016 [TBL] [Abstract][Full Text] [Related]
8. WHO Expert Committee on Specifications for Pharmaceutical Preparations. World Health Organization World Health Organ Tech Rep Ser; 2005; 929():1-142, backcover. PubMed ID: 16353684 [TBL] [Abstract][Full Text] [Related]
9. The regulation of biopharmaceuticals. Weisbroth N Qual Assur; 1993; 2(1-2):147-51. PubMed ID: 8156202 [No Abstract] [Full Text] [Related]
10. [Regulations for industrial establishments devoted to the manufacture of raw materials for compounding drugs and for laboratories or factories]. Salud Publica Mex; 1982; 24(2):212-9. PubMed ID: 7112260 [No Abstract] [Full Text] [Related]
11. WHO Expert Committee on Specifications for Pharmaceutical Preparations. World Health Organ Tech Rep Ser; 2008; (948):1-138. PubMed ID: 18557474 [TBL] [Abstract][Full Text] [Related]
12. [Quality of medicines in least developed countries]. Videau JY Med Trop (Mars); 2006 Dec; 66(6):533-7. PubMed ID: 17286015 [TBL] [Abstract][Full Text] [Related]
13. WHO expert committee on specifications for pharmaceutical preparations. Fortieth report. WHO Expert Committee on Specifications for Pharmaceutical Preparations World Health Organ Tech Rep Ser; 2006; 937():1-461, back cover. PubMed ID: 16836287 [TBL] [Abstract][Full Text] [Related]
15. The poor quality of streptokinase products in use in developing countries. Longstaff C; Thelwell C; Whitton C J Thromb Haemost; 2005 May; 3(5):1092-3. PubMed ID: 15869616 [No Abstract] [Full Text] [Related]
16. [Guidelines for introducing new drugs for medical use in Poland and control of their quality]. Danysz A Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1673-4. PubMed ID: 6522321 [No Abstract] [Full Text] [Related]
17. [The cheapest synonymous preparations--a proposal with unwanted consequences]. Rytter E Tidsskr Nor Laegeforen; 1989 Nov; 109(32):3359-60. PubMed ID: 2595709 [No Abstract] [Full Text] [Related]
18. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories. Jimenez FA Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711 [No Abstract] [Full Text] [Related]
19. The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality? Marsh DA; Hoar ME Contemp Pharm Pract; 1982; 5(2):130-5. PubMed ID: 10317245 [TBL] [Abstract][Full Text] [Related]
20. [How to assure the quality of a medicinal product ]. Agosti ME Medicina (B Aires); 2003; 63(5):450-2. PubMed ID: 14628657 [No Abstract] [Full Text] [Related] [Next] [New Search]